Last reviewed · How we verify
Pembrolizumab Injection [Keytruda]
At a glance
| Generic name | Pembrolizumab Injection [Keytruda] |
|---|---|
| Also known as | Keytruda, Cisplatin, 5-FU, MK-3475, Pembrolizumab |
| Sponsor | SMT bio Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pembrolizumab Injection [Keytruda] CI brief — competitive landscape report
- Pembrolizumab Injection [Keytruda] updates RSS · CI watch RSS
- SMT bio Co., Ltd. portfolio CI